Extended anticoagulation tied to major bleeding risk
Sep 13, 2021
Long-term risks and consequences are considerable for patients receiving VKA, DOAC after first unprovoked VTE
Low-dose aspirin does not reduce adverse heart, lung outcomes in stable COVID patients: study
By
Alicia Lasek
Oct 19, 2021
Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19, researchers...
Anticoagulants advised following certain COVID-19 acute-care stays
By
Alicia Lasek
Nov 29, 2021
Clinicians disagree about the need for continued anticoagulation therapy to reduce blood clot risks following COVID-19 hospitalization. A new study suggests that patients with certain medical histories...
Ask the care expert … about anticoagulants
By
Sherrie Dornberger
Jul 01, 2014
What tips do you have for working with anticoagulants?